EPA v. MEDTRONIC XOMED

Case summary

1/17/13 - NOTICE OF DETERMINATION ISSUED. ON JULY 21, 2011, MEDTRONIC SUBMITTED A SELF-DISCLOSURE TO EPA AND THE STATE OF FLORIDA FOR VIOLATIONS OF EPCRA 313 AND 40 CFR 372.30 AT ITS FACILITY LOCATED IN JACKSONVILLE, FL. MEDTRONIC ALSO PROVIDED ADD'L INFORMATION TO SUPPORT THAT THE COMPANY MET THE NINE ELEMENTS OF THE AUDIT POLICY, INCLUDING DOCUMENTATION IDENTIFYING THE CORRECTIVE ACTIONS THAT WERE TAKEN. THE VIOLATIONS ARE: - FAILURE TO TIMELY SUBMIT TRI REPORTS FOR THE REPORTING YEARS 2008 AND 2009 FOR 2-CHLORO-1,1,1,2-TETRAFLUOPETHANE TO THE EPA AND THE STATE OR FLORIDA AS REQUIRED BY EPCRA 313.

Defendants (1)

• MEDTRONIC XOMEDNamed in settlement

Facilities (4)

• MEDTRONIC ENT

  6743 SOUTHPOINT DR. N., JACKSONVILLE, FL, 32216

  Registry ID: 110000361992

• MEDTRONIC ENT

  6743 SOUTHPOINT DR. N., JACKSONVILLE, FL, 32216

  Registry ID: 110000361992

• MEDTRONIC ENT

  6743 SOUTHPOINT DR. N., JACKSONVILLE, FL, 32216

  Registry ID: 110000361992

• MEDTRONIC ENT

  6743 SOUTHPOINT DR. N., JACKSONVILLE, FL, 32216

  Registry ID: 110000361992

Statutes cited

• EPCRA 313 — Toxic Chemical Release Reporting (TRI)

Enforcement conclusions (1)

• MEDTRONIC XOMEDentered 2013-01-16

  Primary law: EPCRA

Timeline (3 milestones)

• 2013-01-16Final Order Issued
• 2013-01-16Enforcement Action Closed
• 2013-04-01Enforcement Action Data Entered